HL2351

BIOLOGICAL2 trials

Sponsors

Handok Inc.

Conditions

Cryopyrin-Associated Periodic Syndromes (CAPS)Healthy Volunteers

Phase 1

A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study

CompletedNCT02175056

Handok Inc.Healthy Volunteers

Start: 2014-05-31End: 2015-02-28Updated: 2015-10-06

Phase 2

HL2351 CAPS Phase II Study

TerminatedNCT02853084

Handok Inc.Cryopyrin-Associated Periodic Syndromes (CAPS)

Start: 2015-10-31End: 2019-01-31Target: 8Updated: 2017-01-04